1. 144Entrainment of induced ventricular fibrillation: a human feasibility and proof of concept study. (10th October 2018) Authors: Begg, G A; Holden, A V; Bounford, K; Stegemann, B; Tayebjee, M H Journal: Europace Issue: Volume 20(2018)Supplement 4 Page Start: iv61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 85 Prediction of response to biventricular pacing from dyssynchrony indices: the absolute limit on predictability, and its clinical implications. (9th June 2011) Authors: Nijjer, S S; Pabari, P; Stegemann, B; Palmieri, V; Freemantle, N; Hughes, A; Francis, D P Journal: Heart Issue: Volume 97(2011)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective. (24th May 2021) Authors: Leyva, F; Zegard, A; Okafor, O; Stegemann, B; Ludman, P; Qiu, T Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Issue 19 (9th July 2009) Authors: Leyva, F; Foley, P W X; Stegemann, B; Ward, J A; Ng, L L; Frenneaux, M P; Regoli, F; Smith, R E A; Auricchio, A Journal: Heart Issue: Volume 95:Issue 19(2009) Page Start: 1619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Endocardial pacing is not haemodynamically superior to trans-coronary sinus epicardial pacing in cardiac resynchronization therapy: the Endo-Epi CRT study. (24th May 2021) Authors: Okafor, O; Zegard, A; Stegemann, B; Arif, S; De Bono, J; Marshall, H; Leyva, F Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%. (24th May 2021) Authors: Zegard, A; Okafor, O; Debono, J; Kalla, M; Lencioni, M; Marshall, H; Hudsmith, L; Qiu, T; Steeds, R; Stegemann, B; Leyva, F Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease. (24th May 2021) Authors: Zegard, A; Okafor, O; Debono, J; Kalla, M; Lencioni, M; Marshall, H; Hudsmith, L; Qiu, T; Steeds, R; Stegemann, B; Leyva, F Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation. (19th May 2022) Authors: Zegard, A; Okafor, O; Foley, P; Umar, F; Taylor, R; Marshall, H; Stegemann, B; Moody, W; Steeds, R; Halliday, B; Hammersley, D; Jones, R; Prasad, S; Qiu, T; Leyva, F Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗